Table 2: No significant differences between parameters values of patients in the test and control groups before the trial (results represented as mean ± SD values).

Parameter
Control
mean ± SD
LF
mean ± SD

BUN (mg/dL)17.5 ± 8.0416.23 ± 5.55
Serum creatinine (mg/dL)1.05 ± 0.470.996 ± 0.524
AST (IU/L)33.25 ± 18.440.59 ± 19.07
ALT (IU/L)30.1 ± 16.1937.46 ± 27.79
Serum LF (ng/mL)0.186 ± 0.0390.13 ± 0.018
Serum GST enzyme (ng/mL)0.729 ± 0.0730.679 ± 0.076
INF-γ (pg/mL)32.36 ± 4.7632.33 ± 4.65
WBCs (*103 cell/µL)7.55 ± 1.656.12 ± 1.97
Platelet (*103/mm3)217.2 ± 88.76207.6 ± 69.84
CEA (ng/mL)16.07 ± 17.3730.16 ± 50.06
RBCs (*106/µL)4.3 ± 0.414.4 ± 0.63
Neutrophil (%)46.86 ± 7.2145.46 ± 7.37
Hb (g/dL)11.1 ± 2.111.09 ± 1.67

Note: *significant difference .